GO
Loading...

Vertex Pharmaceuticals Inc

More

  • Dow Gains 0.8% as Financials Rebound Monday, 2 Nov 2009 | 5:49 PM ET
    Winterizing Your Portfolio - A CNBC Special Report

    A late rally helped propel the Dow to a positive finish Monday as financial stocks rebounded.

  • Stocks Erase Gains as Financials Slide Monday, 2 Nov 2009 | 1:01 PM ET
    Winterizing Your Portfolio - A CNBC Special Report

    Stocks erased all of their gains Monday after an early surge due to a better-than-expected manufacturing report. Financials led the decline.

  • Biopharma's Bustin' Out All Over Monday, 2 Nov 2009 | 12:32 PM ET

    Over the past few days there's been a remarkable confluence of newsflow, most of it positive, out of biopharma. First the bad news.

  • Dow Jumps Over 100 After ISM Beat Monday, 2 Nov 2009 | 10:30 AM ET
    Winterizing Your Portfolio - A CNBC Special Report

    The Dow shot up more than 100 points Monday after a report showed manufacturing expanded more than expected last month.

  • Futures Regain Ground; Ford, Pharma Higher Monday, 2 Nov 2009 | 7:22 AM ET

    Stock futures pointed to a modest rebound ahead of the open Monday after the Dow and the S&P 500 experienced their biggest one-day percentage drops Friday since July 2.

  • Longest Monthly Streak for the Nasdaq in 14 Years? Thursday, 22 Oct 2009 | 7:26 AM ET

    There’s still a week-and-a-half left in the month, but the markets are currently maintaining yet another month of gains.

  • Your First Move For Thursday October 1st Wednesday, 30 Sep 2009 | 6:35 PM ET

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Four Hot Biotech Stocks to Buy: Analyst Thursday, 11 Jun 2009 | 10:41 AM ET

    Dr. Mark Monane, senior biotech analyst at Needham & Co., named some biotech stocks that look attractive.

  • Stocks Go Negative In Last Hour Tuesday, 28 Apr 2009 | 6:01 PM ET

    Stocks surrendered earlier gains and fell modestly on Tuesday largely due to fresh worries that major banks may need to raise more money.

  • Halftime Report: Stress Tests, Who's Making The Grade? Tuesday, 28 Apr 2009 | 1:11 PM ET

    Stocks traded only modestly lower Tuesday, despite concerns that if major banks need to raise more money a financial hurricane may be brewing.

  • Lightning Round: Cisco, US Steel and More Monday, 6 Apr 2009 | 8:26 PM ET

    Cramer makes the call on viewers' favorite stocks.

  • The "Big Bank Theory" Of Picking Stocks Thursday, 12 Feb 2009 | 1:33 PM ET

    CNBC's "Power Lunch" team asked some of the best and the brightest from America's big financial firms to list the most promising stocks. Strategists from Citigroup, Goldman Sachs, Cowen & Co. and Deutsche Bank offered CNBC their stock picks.

  • A Tale Of Two Industries Tuesday, 13 Jan 2009 | 12:25 PM ET
    Jamie Dimon

    During his lunchtime keynote speech here at the JPMorgan Healthcare Conference JPM Chairman and CEO Jamie Dimon was asked to give his worst-case scenario for the economy. He said that'd be a 1982-type recession lasting about two years and with unemployment "North of 10 percent." Dimon said it would be "Irrational to not be prepared for that."

  • '09 Sector To Watch: Biotech Monday, 5 Jan 2009 | 6:06 PM ET

    Will M&A activity boost biotech stocks in 2009?

  • Vertex's $75,000 Question Friday, 19 Dec 2008 | 3:14 PM ET

    Drug pricing pressure under a Democratic administration be darned. $75,000. That's not a salary figure. That's the price one biotech analyst says Vertex Pharmaceuticals and its partner Johnson & Johnson might be able to charge--possibly even more--for their Hepatitis C drug.

  • Mad Mail: Throw Merck Out With Schering? Wednesday, 3 Sep 2008 | 6:36 PM ET

    Plus, Cramer make the call on IBM, CSX, Celgene and more.

  • Putting Cramer in Context Friday, 15 Aug 2008 | 7:18 PM ET

    This is how you balance Mad Money stock picks with your own portfolio.

  • Speculating on Alexion Pharma Thursday, 14 Aug 2008 | 11:44 PM ET

    This biotech sells its treatment to a niche clientele for big money.

  • Worst House, Best Neighborhood Wednesday, 13 Aug 2008 | 11:09 PM ET

    Vertex Pharma is lagging its peers. But biotech is so good right now, it might not matter.

  • Regulatory "Risky Business" for Pharma & Biotech Monday, 28 Apr 2008 | 11:56 AM ET
    Risky Business

    It's a big day for pipeline progress...or not. Late Friday, Merck and Schering-Plough announced that the Food and Drug Administration won't approve their combo Claritin-Singulair combo pill for allergies.